Skip to main content

Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for elevated levels of serum alanine aminotransferase (ALT) by ND2-237 Leu/Met genotype and smoking status

From: NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies effects of cigarette smoking on risk of elevated levels of serum liver enzyme in male Japanese health check-up examinees: a cross-sectional study

Genotype and number of cigarettes smoked daily

Frequency

OR (95% CI)

Adjusted OR†(95% CI)

Normal levels of serum ALT

Elevated levels of serum ALT

serum ALT levels ≤ 30 U/L

serum ALT levels > 30 U/L

ND2-237Leu

    

0 (never- or ex-smoker)

101 (67.8)

48 (32.2)

1 (reference)

1 (reference)

1-20

55 (78.6)

15 (21.4)

0.574 (0.295-1.117)

0.525 (0.237-1.166)

>20

27 (84.4)

5 (15.6)

0.390 (0.141-1.074)

0.462 (0.143-1.492)

   

P for trend = 0.026

P for trend = 0.120

ND2-237Met

    

0 (never- or ex-smoker)

74 (74.8)

25 (25.2)

1 (reference)

1 (reference)

1-20

31 (67.4)

15 (32.6)

1.432 (0.660-3.079)

1.826 (0.723-4.614)

>20

13 (52.0)

12 (48.0)

2.732 (1.104-6.762)*

3.017 (1.064-8.560)*

   

P for trend = 0.031

P for trend = 0.032

 

serum ALT levels < 25 U/L

serum ALT levels ≥ 25 U/L

  

ND2-237Leu

    

0 (never- or ex-smoker)

82 (55.0)

67 (45.0)

1 (reference)

1 (reference)

1-20

48 (68.6)

22 (31.4)

0.561 (0.308-1.021)

0.501 (0.248-1.010)

>20

26 (81.3)

6 (18.7)

0.282 (0.110-0.726)**

0.255 (0.084-0.776)*

   

P for trend = 0.003

P for trend = 0.010

ND2-237Met

    

0 (never- or ex-smoker)

54 (54.6)

45 (45.4)

1 (reference)

1 (reference)

1-20

28 (60.9)

18 (39.1)

0.771 (0.378-1.572)

0.828 (0.365-1.879)

>20

10 (40.0)

15 (60.0)

1.800 (0.737-4.395)

1.675 (0.633-4.435)

   

P for trend = 0.408

P for trend = 0.459

  1. †OR adjusted for age, body mass index, habitual alcohol consumption, coffee consumption, antihypertensive treatment and antidiabetic treatment.
  2. *P < 0.05, **P < 0.01.